255 related articles for article (PubMed ID: 26053176)
1. Nevirapine Concentration in Hair Samples Is a Strong Predictor of Virologic Suppression in a Prospective Cohort of HIV-Infected Patients.
Baxi SM; Greenblatt RM; Bacchetti P; Jin C; French AL; Keller MJ; Augenbraun MH; Gange SJ; Liu C; Mack WJ; Gandhi M;
PLoS One; 2015; 10(6):e0129100. PubMed ID: 26053176
[TBL] [Abstract][Full Text] [Related]
2. Nevirapine hair and plasma concentrations and HIV-1 viral suppression among HIV infected ante-partum and post-partum women attended in a mother and child prevention program in Maputo city, Mozambique.
Cuco RM; Loquiha O; Juga A; Couto A; Meggi B; Vubil A; Sevene E; Osman N; Temermam M; Degomme O; Sidat M; Bhatt N
PLoS One; 2022; 17(2):e0261522. PubMed ID: 35143515
[TBL] [Abstract][Full Text] [Related]
3. Atazanavir concentration in hair is the strongest predictor of outcomes on antiretroviral therapy.
Gandhi M; Ameli N; Bacchetti P; Anastos K; Gange SJ; Minkoff H; Young M; Milam J; Cohen MH; Sharp GB; Huang Y; Greenblatt RM
Clin Infect Dis; 2011 May; 52(10):1267-75. PubMed ID: 21507924
[TBL] [Abstract][Full Text] [Related]
4. Protease inhibitor levels in hair strongly predict virologic response to treatment.
Gandhi M; Ameli N; Bacchetti P; Gange SJ; Anastos K; Levine A; Hyman CL; Cohen M; Young M; Huang Y; Greenblatt RM;
AIDS; 2009 Feb; 23(4):471-8. PubMed ID: 19165084
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetic parameters of nevirapine and efavirenz in relation to antiretroviral efficacy.
Leth FV; Kappelhoff BS; Johnson D; Losso MH; Boron-Kaczmarska A; Saag MS; Livrozet JM; Hall DB; Leith J; Huitema AD; Wit FW; Beijnen JH; Lange JM;
AIDS Res Hum Retroviruses; 2006 Mar; 22(3):232-9. PubMed ID: 16545009
[TBL] [Abstract][Full Text] [Related]
6. Nevirapine concentration in nonstimulated saliva: an alternative to plasma sampling in children with human immunodeficiency virus infection.
Rakhmanina NY; Capparelli EV; van den Anker JN; Williams K; Sever JL; Spiegel HM; Soldin SJ
Ther Drug Monit; 2007 Feb; 29(1):110-7. PubMed ID: 17304158
[TBL] [Abstract][Full Text] [Related]
7. Nevirapine concentrations in saliva measured by thin layer chromatography and self-reported adherence in patients on antiretroviral therapy at Kilimanjaro Christian Medical Centre, Tanzania.
George L; Muro EP; Ndaro A; Dolmans W; Burger DM; Kisanga ER
Ther Drug Monit; 2014 Jun; 36(3):366-70. PubMed ID: 24305625
[TBL] [Abstract][Full Text] [Related]
8. Maternal 12-month response to antiretroviral therapy following prevention of mother-to-child transmission of HIV type 1, Ivory Coast, 2003-2006.
Coffie PA; Ekouevi DK; Chaix ML; Tonwe-Gold B; Clarisse AB; Becquet R; Viho I; N'dri-Yoman T; Leroy V; Abrams EJ; Rouzioux C; Dabis F
Clin Infect Dis; 2008 Feb; 46(4):611-21. PubMed ID: 18197758
[TBL] [Abstract][Full Text] [Related]
9. Plasma nevirapine concentrations predict virological and adherence failure in Kenyan HIV-1 infected patients with extensive antiretroviral treatment exposure.
Kimulwo MJ; Okendo J; Aman RA; Ogutu BR; Kokwaro GO; Ochieng DJ; Muigai AW; Oloo FA; Ochieng W
PLoS One; 2017; 12(2):e0172960. PubMed ID: 28235021
[TBL] [Abstract][Full Text] [Related]
10. Does an increase in nevirapine plasma levels cause complete virologic suppression in patients experiencing early virologic failure?
de Requena DG; Núñez M; Gallego O; Jiménez-Nácher I; González-Lahoz J; Soriano V
HIV Clin Trials; 2002; 3(6):463-7. PubMed ID: 12501129
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetic evaluation and short-term activity of stavudine, nevirapine, and nelfinavir therapy in HIV-1-infected adults.
Skowron G; Leoung G; Hall DB; Robinson P; Lewis R; Grosso R; Jacobs M; Kerr B; MacGregor T; Stevens M; Fisher A; Odgen R; Yen-Lieberman B
J Acquir Immune Defic Syndr; 2004 Apr; 35(4):351-8. PubMed ID: 15097151
[TBL] [Abstract][Full Text] [Related]
12. Association between social psychological status and efavirenz and nevirapine plasma concentration among HIV patients in Kenya.
Ngayo MO; Oluka M; Bulimo WD; Okalebo FA
Sci Rep; 2021 Nov; 11(1):22071. PubMed ID: 34764325
[TBL] [Abstract][Full Text] [Related]
13. Hair concentrations of antiretrovirals predict viral suppression in HIV-infected pregnant and breastfeeding Ugandan women.
Koss CA; Natureeba P; Mwesigwa J; Cohan D; Nzarubara B; Bacchetti P; Horng H; Clark TD; Plenty A; Ruel TD; Achan J; Charlebois ED; Kamya MR; Havlir DV; Gandhi M
AIDS; 2015 Apr; 29(7):825-30. PubMed ID: 25985404
[TBL] [Abstract][Full Text] [Related]
14. Rate of viral load change and adherence of HIV adult patients treated with Efavirenz or Nevirapine antiretroviral regimens at 24 and 48 weeks in Yaoundé, Cameroon: a longitudinal cohort study.
Chendi BH; Okomo Assoumou MC; Jacobs GB; Yekwa EL; Lyonga E; Mesembe M; Eyoh A; Ikomey GM
BMC Infect Dis; 2019 Feb; 19(1):194. PubMed ID: 30808298
[TBL] [Abstract][Full Text] [Related]
15. Three generic nevirapine-based antiretroviral treatments in Chinese HIV/AIDS patients: multicentric observation cohort.
Li T; Dai Y; Kuang J; Jiang J; Han Y; Qiu Z; Xie J; Zuo L; Li Y
PLoS One; 2008; 3(12):e3918. PubMed ID: 19081791
[TBL] [Abstract][Full Text] [Related]
16. Virologic suppression in nevirapine-exposed HIV-infected infants initiating antiretroviral therapy in rural Uganda.
Kay J; Wanzira H; Sandison T; Kakuru A; Bigira V; Kamya M; Homsy J; Tappero JW; Havlir D; Dorsey G; Ruel T
J Trop Pediatr; 2012 Jun; 58(3):194-9. PubMed ID: 21930666
[TBL] [Abstract][Full Text] [Related]
17. Minor resistant variants in nevirapine-exposed infants may predict virologic failure on nevirapine-containing ART.
MacLeod IJ; Rowley CF; Thior I; Wester C; Makhema J; Essex M; Lockman S
J Clin Virol; 2010 Jul; 48(3):162-7. PubMed ID: 20427228
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetic analysis of nevirapine extended release 400 mg once daily vs nevirapine immediate release 200 mg twice daily formulation in treatment-naïve patients with HIV-1 infection.
Yong CL; Gathe JC; Knecht G; Orrell C; Mallolas J; Podzamczer D; Trottier B; Zhang W; Sabo JP; Vinisko R; Drulak M; Quinson AM
HIV Clin Trials; 2017; 18(5-6):189-195. PubMed ID: 29210627
[TBL] [Abstract][Full Text] [Related]
19. Assessment of HIV antiretroviral therapy adherence by measuring drug concentrations in hair among children in rural Uganda.
Olds PK; Kiwanuka JP; Nansera D; Huang Y; Bacchetti P; Jin C; Gandhi M; Haberer JE
AIDS Care; 2015; 27(3):327-32. PubMed ID: 25483955
[TBL] [Abstract][Full Text] [Related]
20. Nevirapine- versus lopinavir/ritonavir-based initial therapy for HIV-1 infection among women in Africa: a randomized trial.
Lockman S; Hughes M; Sawe F; Zheng Y; McIntyre J; Chipato T; Asmelash A; Rassool M; Kimaiyo S; Shaffer D; Hosseinipour M; Mohapi L; Ssali F; Chibowa M; Amod F; Halvas E; Hogg E; Alston-Smith B; Smith L; Schooley R; Mellors J; Currier J;
PLoS Med; 2012; 9(6):e1001236. PubMed ID: 22719231
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
